BrightGene Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name BrightGene Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 13 active records with this name as holder; 34 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
44 acceptance records as first applicant, grouped into 18 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
BGM1812注射液 · No verified English name 3 records · Latest accepted 2026/10/22
Supplement · 2New drug · 1
BGM0504片 · No verified English name 9 records · Latest accepted 2026/07/29
New drug · 6Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600931 | New drug | 2026/07/29 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2600930 | New drug | 2026/07/29 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2600929 | New drug | 2026/07/29 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2600105 | Supplement | 2026/04/10 | BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CXHB2600104 | Supplement | 2026/04/10 | BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CXHB2600103 | Supplement | 2026/04/10 | BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2500681 | New drug | 2025/07/10 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500680 | New drug | 2025/07/10 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500679 | New drug | 2025/07/10 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
BGM0504注射液 · No verified English name 10 records · Latest accepted 2026/06/11
New drug · 4Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600089 | New drug | 2026/06/11 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600088 | New drug | 2026/06/11 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600087 | New drug | 2026/06/11 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600086 | New drug | 2026/06/11 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2600002 | Supplement | 2026/01/06 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2600001 | Supplement | 2026/01/06 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2500317 | Supplement | 2025/12/02 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2500316 | Supplement | 2025/12/02 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2500315 | Supplement | 2025/12/02 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2500314 | Supplement | 2025/12/02 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation 2 records · Latest accepted 2026/01/22
Generic · 2
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2026/01/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600127 | Supplement | 2026/01/21 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
Ethyl Iosapentate Capsules 2 records · Latest accepted 2025/04/29
Generic · 2
伏环孢素软胶囊 · No verified English name 1 records · Latest accepted 2025/01/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2500031 | Generic | 2025/01/27 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
Ferric Carboxymaltose Injection 1 records · Latest accepted 2025/01/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500520 | Generic | 2025/01/27 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
Entecavir Tablets 4 records · Latest accepted 2024/02/09
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400255 | Supplement | 2024/02/09 | BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2400254 | Supplement | 2024/02/09 | BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201586 | Supplement | 2022/09/03 | BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201585 | Supplement | 2022/09/03 | BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
Iopromide Injection 2 records · Latest accepted 2023/10/08
Generic · 2
磷酸奥司他韦干糖浆 · No verified English name 1 records · Latest accepted 2023/08/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301854 | Supplement | 2023/08/21 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
Regadenoson Injection 1 records · Latest accepted 2023/08/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302096 | Generic | 2023/08/12 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
Dienogest Tablets 1 records · Latest accepted 2023/02/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300580 | Generic | 2023/02/20 | BrightGene Pharmaceutical Co., Ltd.; ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. | CDE ↗ |
Cinacalcet Hydrochloride Tablets 1 records · Latest accepted 2022/02/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200322 | Generic | 2022/02/17 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
Fondaparinux Sodium Injection 1 records · Latest accepted 2022/01/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200201 | Generic | 2022/01/27 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
硫酸阿托品滴眼液 · No verified English name 2 records · Latest accepted 2022/01/21
New drug · 2
Carboprost Tromethamine Injection 1 records · Latest accepted 2022/01/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200070 | Generic | 2022/01/13 | BrightGene Pharmaceutical Co., Ltd.; Jiangxi Ai Shi Te Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Eribulin Mesilate Injection 1 records · Latest accepted 2021/07/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101455 | Generic | 2021/07/21 | BrightGene Pharmaceutical Co., Ltd.; Wuxi Zi Shan Pharma Co., Ltd. romanized | CDE ↗ |
Changes in the last 90 days
4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 2 applicationsNo longer listed under review: 2 applications
- 2026/11/14No longer listed under review
Ethyl Iosapentate Capsules
CYHS2501609
Fact date: 2026/11/14 · Date added to this site: 2026/11/14
Accepted: 2025/04/29
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/14No longer listed under review
Ethyl Iosapentate Capsules
CYHS2404522
Fact date: 2026/11/14 · Date added to this site: 2026/11/14
Accepted: 2024/12/26
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/22Accepted
BGM1812注射液 · No verified English name
CXHB2600443
Fact date: 2026/10/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/10/22Accepted
BGM1812注射液 · No verified English name
CXHB2600442
Fact date: 2026/10/22 · Date added to this site: 2026/10/22
View source ↗
Under review
9 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| BGM1812注射液 · No verified English name | CXHB2600443 | Supplement | 2026/10/22 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| BGM1812注射液 · No verified English name | CXHB2600442 | Supplement | 2026/10/22 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| BGM0504注射液 · No verified English name | CXHS2600089 | New drug | 2026/06/11 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| BGM0504注射液 · No verified English name | CXHS2600088 | New drug | 2026/06/11 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| BGM0504注射液 · No verified English name | CXHS2600087 | New drug | 2026/06/11 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| BGM0504注射液 · No verified English name | CXHS2600086 | New drug | 2026/06/11 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation | CYHS2600253 | Generic | 2026/01/22 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation | CYHS2600252 | Generic | 2026/01/22 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Ferric Carboxymaltose Injection | CYHS2500520 | Generic | 2025/01/27 | BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
13 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Iopromide Injection | BrightGene Pharmaceutical Co., Ltd. | BrightGene Pharmaceutical Co., Ltd. | 国药准字H20254086 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopromide Injection | BrightGene Pharmaceutical Co., Ltd. | BrightGene Pharmaceutical Co., Ltd. | 国药准字H20254085 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dienogest Tablets | BrightGene Pharmaceutical Co., Ltd. | ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. | 国药准字H20249468 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carboprost Tromethamine Injection | BrightGene Pharmaceutical Co., Ltd. | Jiangxi Ai Shi Te Pharmaceutical Co., Ltd. romanized | 国药准字H20243336 | 2024/03/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 磷酸奥司他韦颗粒 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | BrightGene Pharmaceutical Co., Ltd. | 国药准字H20234694 | 2023/12/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eribulin Mesilate Injection | Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | Wuxi Taxus Pharmaceutical Co., Ltd | 国药准字H20233223 | 2023/02/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Voriconazole for Injection | BrightGene Pharmaceutical Co., Ltd. | BrightGene Pharmaceutical Co., Ltd. | 国药准字H20233069 | 2023/01/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | BrightGene Pharmaceutical Co., Ltd. | BrightGene Pharmaceutical Co., Ltd. | 国药准字H20223402 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Argatroban Injection | BrightGene Pharmaceutical Co., Ltd. | BrightGene Pharmaceutical Co., Ltd. | 国药准字H20223094 | 2022/03/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Entecavir Tablets | BrightGene Pharmaceutical Co., Ltd. | Hua Yi Tai Kang Pharma Co., Ltd. romanized | 国药准字H20223011 | 2022/01/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Entecavir Tablets | BrightGene Pharmaceutical Co., Ltd. | Hua Yi Tai Kang Pharma Co., Ltd. romanized | 国药准字H20223010 | 2022/01/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | BrightGene Pharmaceutical Co., Ltd. | BrightGene Pharmaceutical Co., Ltd. | 国药准字H20213619 | 2021/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Micafungin Sodium for Injection | BrightGene Pharmaceutical Co., Ltd. | BrightGene Pharmaceutical Co., Ltd. | 国药准字H20203155 | 2021/06/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
34 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| BGM0504 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20260000372 | I | 2026/04/30 | CDE ↗ |
| 盐酸曲恩汀 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20250001390 | I | 2025/12/25 | CDE ↗ |
| 芦比替定 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20250000347 | I | 2025/04/11 | CDE ↗ |
| 麦考酚钠 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20240001416 | A | 2026/05/21 | CDE ↗ |
| 羧基麦芽糖铁 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20240001430 | I | 2024/12/24 | CDE ↗ |
| 肾上腺素 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20230001214 | A | 2025/05/28 | CDE ↗ |
| 重酒石酸间羟胺 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20230000701 | A | 2025/04/09 | CDE ↗ |
| 盐酸多巴胺 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20230000687 | A | 2025/01/06 | CDE ↗ |
| 重酒石酸去甲肾上腺素 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20230000409 | A | 2024/11/29 | CDE ↗ |
| 碘普罗胺 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20230000628 | A | 2025/05/24 | CDE ↗ |
| 硫酸艾沙康唑 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20230000572 | A | 2025/03/14 | CDE ↗ |
| 瑞加诺生 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20230000573 | A | 2025/03/25 | CDE ↗ |
| 地诺孕素 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20220000618 | A | 2025/01/09 | CDE ↗ |
| 舒更葡糖钠 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20220000191 | A | 2025/05/30 | CDE ↗ |
| 艾地骨化醇 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20220000173 | A | 2026/06/03 | CDE ↗ |
| 依维莫司 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20210001286 | A | 2025/05/31 | CDE ↗ |
| 溴夫定 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20210001219 | A | 2025/07/29 | CDE ↗ |
| 硫酸阿托品 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20210001099 | A | 2024/01/23 | CDE ↗ |
| 卡前列素氨丁三醇 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20210000614 | A | 2024/04/13 | CDE ↗ |
| 甲磺酸艾立布林 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20210000505 | A | 2023/03/24 | CDE ↗ |
| 吡美莫司 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20210000257 | A | 2024/04/19 | CDE ↗ |
| 富马酸丙酚替诺福韦 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20200000740 | A | 2025/06/07 | CDE ↗ |
| 泊沙康唑 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20190021534 | A | 2025/10/14 | CDE ↗ |
| 恩替卡韦 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20190021456 | A | 2026/08/25 | CDE ↗ |
| 米卡芬净钠 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20190021178 | A | 2024/04/19 | CDE ↗ |
| 恩替卡韦 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20190001707 | A | 2025/04/04 | CDE ↗ |
| 磷酸奥司他韦 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20180001370 | A | 2026/05/08 | CDE ↗ |
| 盐酸帕罗西汀 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20170000926 | A | 2023/06/13 | CDE ↗ |
| 米卡芬净钠 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20170000763 | A | 2023/12/27 | CDE ↗ |
| 磺达肝癸钠 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20170000761 | A | 2026/01/10 | CDE ↗ |
| 艾司奥美拉唑钠 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20170000673 | A | 2023/07/26 | CDE ↗ |
| 醋酸卡泊芬净 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20170000599 | A | 2024/08/29 | CDE ↗ |
| 奥拉西坦 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20170000585 | A | 2023/07/26 | CDE ↗ |
| 阿加曲班 · No verified English name | BrightGene Pharmaceutical Co., Ltd. | Y20170000226 | A | 2025/01/04 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
28 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 地塞米松眼用混悬注射液 · No verified English name | CYHS2602155 | Generic | 2026/08/28 | Suzhou Ou Kang Wei Shi Bio Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Fondaparinux Sodium Injection | CYHB2601004 | Supplement | 2026/05/27 | Anhui Jia He Pharma Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Caspofungin Acetate for Injection | CYHB2600325 | Supplement | 2026/02/11 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Caspofungin Acetate for Injection | CYHB2600324 | Supplement | 2026/02/11 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Ioversol Injection | CYHS2502389 | Generic | 2025/07/05 | Anhui Jia He Pharma Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Ioversol Injection | CYHS2500275 | Generic | 2025/01/14 | Shandong Qidu Pharmaceutical Co., Ltd.; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Fondaparinux Sodium Injection | CYHB2500109 | Supplement | 2025/01/14 | Di Kang Bei (Suzhou) Biopharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| 噻托溴铵吸入喷雾剂 · No verified English name | CYHS2500201 | Generic | 2025/01/10 | Ai Te Mei (Suzhou) Pharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| 噻托溴铵奥达特罗吸入喷雾剂 · No verified English name | CYHS2404540 | Generic | 2024/12/26 | Ai Te Mei (Suzhou) Pharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Isavuconazonium Sulfate for Injection | CYHS2404300 | Generic | 2024/12/11 | Shang Yao Dong Ying (Jiangsu) Pharma Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Polymyxin B sulfate for Injection | CYHS2404145 | Generic | 2024/12/03 | Shandong Xu Lie Bio Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| 磷酸奥司他韦颗粒 · No verified English name | CYHB2401699 | Supplement | 2024/10/24 | Jiangsu Xin Li Yuan Biopharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Cinacalcet Hydrochloride Tablets | CYHB2401401 | Supplement | 2024/09/10 | Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized; Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | CDE ↗ |
| 磷酸奥司他韦颗粒 · No verified English name | CYHB2400978 | Supplement | 2024/07/04 | Jiangsu Xin Li Yuan Biopharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| 吸入用布地奈德混悬液 · No verified English name | CYHS2401818 | Generic | 2024/06/18 | Ai Te Mei (Suzhou) Pharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CYHB2400685 | Supplement | 2024/05/22 | Guangzhou Nan Xin Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Metaraminol Tartrate Injection | CYHS2401477 | Generic | 2024/05/17 | Guangzhou Hui Feng De Bio Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Norepinephrine Bitartrate Injection | CYHS2400143 | Generic | 2024/01/10 | Guangzhou Hui Feng De Bio Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| 吸入用布地奈德混悬液 · No verified English name | CYHS2302443 | Generic | 2023/09/11 | Ai Te Mei (Suzhou) Pharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Everolimus Tablets | CYHS2201796 | Generic | 2022/10/21 | Di Kang Bei (Suzhou) Biopharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| 磷酸奥司他韦干糖浆 · No verified English name | CYHS2200631 | Generic | 2022/04/22 | Di Kang Bei (Suzhou) Biopharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| 磷酸奥司他韦干糖浆 · No verified English name | CYHS2200630 | Generic | 2022/04/22 | Di Kang Bei (Suzhou) Biopharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Caspofungin Acetate for Injection | CYHS2101499 | Generic | 2021/07/30 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Caspofungin Acetate for Injection | CYHS2101498 | Generic | 2021/07/30 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Fondaparinux Sodium Injection | CYHS2100212 | Generic | 2021/02/21 | Shenyang Shuang Ding Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Caspofungin Acetate for Injection | CYHB2101006 | Supplement | 2021/02/18 | Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Caspofungin Acetate for Injection | CYHB2101005 | Supplement | 2021/02/18 | Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
| Fondaparinux Sodium Injection | CYHB2100187 | Supplement | 2021/01/28 | Yang Zi Jiang Pharma Group Jiangsu Zi Long Pharma Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.